Second clinical candidate from HUTCHMED’s next-generation ATTC platform —— Leveraging synergy through simultaneous inhibition of PAM pathway ...
EGFR-positive lung cancer is more common in non-smokers (particularly those with adenocarcinoma) and younger adults, as it often develops from a single genetic mutation rather than widespread DNA ...
BUFFALO, N.Y. — For decades, pharmacists and medical institutions have relied on the Cockcroft-Gault (C-G) estimated creatinine clearance assessment to determine medication dosing and treatment for ...
New study reveals distinct gene regulatory networks that enable hyaline cartilage formation without hypertrophy Mesenchymal ...
Sustainability is becoming a commercial requirement in the global events industry, writes John Arvanitakis, chairperson of ...
Hong Kong, Shanghai Friday, March 6, 2026, 10:00 Hrs [IST] ...
The Army National Guard will present the newly rebranded FORGE Scholastic Esports Championship, returning May 15–17, 2026, to the Boeing Center at Tech Port San Antonio. Hosted and produced by Rally ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...
First Commercial Product Glecirasib Approved and Added to China's NRDL pan-KRAS and Innovative ADC Pipeline Continue to Advance BEIJING, SHANGHAI and BOSTON, March 10, 2026 /PRNewswire/ -- Jacobio ...
Lower eGFR and higher urinary protein-to-creatinine ratio were associated with greater risks for cognitive impairment across the chronic kidney disease spectrum, according to study data published in ...
The ATTC platform integrates monoclonal antibodies with small-molecule inhibitor payloads to provide dual mechanisms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results